To evaluate the good prognosis of lung adenocarcinoma (LUAD) and skin cutaneous melanoma (SKCM) with high IL‐2 expression, infiltration of antitumor immune cells within the tumor sites were examined. This evidence concerns the gene IL2 and neoplasm.